Status:
UNKNOWN
High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Chronic Kidney Failure
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hem...
Detailed Description
Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy. Hemodiafiltratio...
Eligibility Criteria
Inclusion
- Subject has end-stage renal disease.
- Subject has been on regular dialysis treatment for at least 6 months.
- Subject has autologous vascular access.
- Subject is offered thrice weekly hemodialysis.
- Subject is offered 4 hours duration hemodialysis.
Exclusion
- Infectious disease
- Poor echocardiographic window that was unsuitable for interpretation
Key Trial Info
Start Date :
December 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 20 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03456232
Start Date
December 21 2017
End Date
March 20 2018
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong General Hospital
Guangzhou, Guangdong, China, 510080